Tricida, Inc. Common Stock

TCDA

Market cap $6.27M

LOS ANGELES--(BUSINESS WIRE)--SierraConstellation Partners (“SCP”), a national interim management and advisory firm, has been awarded top industry accolades for the firm's work on the restructuring of Tricida, Inc. (“Tricida”), a clinical-stage pharmaceutical company focused on the development and commercialization of a drug for the treatment of chronic kidney disease. SCP was awarded: The M&A Advisor Turnaround Award for Healthcare/Life Sciences Deal of the Year (Over $100MM) The M&A A.